Compile Data Set for Download or QSAR
maximum 50k data
Found 75 Enz. Inhib. hit(s) with all data for entry = 6213
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116216(US8637502, 56)
Affinity DataKi:  4nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116220(US8637502, 60)
Affinity DataKi:  5.60nM ΔG°:  -43.8kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116200(US8637502, 12)
Affinity DataKi:  8.90nM ΔG°:  -42.7kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116198(US8637502, 17)
Affinity DataKi:  11.5nM ΔG°:  -42.1kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116217(US8637502, 57)
Affinity DataKi:  13nM ΔG°:  -41.8kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116199(US8637502, 9)
Affinity DataKi:  22.8nM ΔG°:  -40.5kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116204(US8637502, 16)
Affinity DataKi:  32.6nM ΔG°:  -39.7kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116202(US8637502, 5)
Affinity DataKi:  35.5nM ΔG°:  -39.5kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116218(US8637502, 67)
Affinity DataKi:  51nM ΔG°:  -38.7kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116210(US8637502, 44)
Affinity DataKi:  52nM ΔG°:  -38.6kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116221(US8637502, 61)
Affinity DataKi:  56nM ΔG°:  -38.5kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116197(US8637502, 18)
Affinity DataKi:  63.2nM ΔG°:  -38.2kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116196(US8637502, 6)
Affinity DataKi:  65nM ΔG°:  -38.1kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116225(US8637502, 87)
Affinity DataKi:  68nM ΔG°:  -38.0kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116212(US8637502, 66)
Affinity DataKi:  89nM ΔG°:  -37.4kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116219(US8637502, 86)
Affinity DataKi: >106nM ΔG°: >-37.0kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116220(US8637502, 60)
Affinity DataKi:  119nM ΔG°:  -36.7kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116196(US8637502, 6)
Affinity DataKi:  167nM ΔG°:  -36.0kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116217(US8637502, 57)
Affinity DataKi:  170nM ΔG°:  -35.9kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116222(US8637502, 58)
Affinity DataKi:  173nM ΔG°:  -35.9kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116203(US8637502, 20)
Affinity DataKi:  229nM ΔG°:  -35.2kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116209(US8637502, 43)
Affinity DataKi:  291nM ΔG°:  -34.7kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116202(US8637502, 5)
Affinity DataKi:  355nM ΔG°:  -34.2kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116200(US8637502, 12)
Affinity DataKi:  439nM ΔG°:  -33.7kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116201(US8637502, 24)
Affinity DataKi:  453nM ΔG°:  -33.7kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116216(US8637502, 56)
Affinity DataKi:  529nM ΔG°:  -35.8kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116213(US8637502, 47)
Affinity DataKi:  559nM ΔG°:  -33.2kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116213(US8637502, 47)
Affinity DataKi:  584nM ΔG°:  -33.1kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116206(US8637502, 10)
Affinity DataKi:  610nM ΔG°:  -33.0kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116205(US8637502, 7)
Affinity DataKi:  620nM ΔG°:  -32.9kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116221(US8637502, 61)
Affinity DataKi:  682nM ΔG°:  -32.7kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116217(US8637502, 57)
Affinity DataKi:  769nM ΔG°:  -34.9kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116199(US8637502, 9)
Affinity DataKi:  825nM ΔG°:  -34.7kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116199(US8637502, 9)
Affinity DataKi:  880nM ΔG°:  -32.1kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116200(US8637502, 12)
Affinity DataKi:  1.30E+3nM ΔG°:  -33.6kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116212(US8637502, 66)
Affinity DataKi:  1.32E+3nM ΔG°:  -31.2kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116220(US8637502, 60)
Affinity DataKi:  1.38E+3nM ΔG°:  -33.4kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116211(US8637502, 29)
Affinity DataKi:  1.53E+3nM ΔG°:  -30.9kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116207(US8637502, 11)
Affinity DataKi:  1.55E+3nM ΔG°:  -30.8kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116214(US8637502, 78)
Affinity DataKi:  1.76E+3nM ΔG°:  -30.5kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116226(US8637502, 80)
Affinity DataKi:  1.78E+3nM ΔG°:  -30.5kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116215(US8637502, 79)
Affinity DataKi:  1.97E+3nM ΔG°:  -30.3kJ/molepH: 7.4 T: 2°CAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116196(US8637502, 6)
Affinity DataKi:  2.20E+3nM ΔG°:  -32.3kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116198(US8637502, 17)
Affinity DataKi:  2.50E+3nM ΔG°:  -32.0kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDelta-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116196(US8637502, 6)
Affinity DataKi:  2.90E+3nM ΔG°:  -31.6kJ/molepH: 7.4 T: 2°CAssay Description:δ-Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 μg m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116206(US8637502, 10)
Affinity DataKi:  2.95E+3nM ΔG°:  -31.6kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116201(US8637502, 24)
Affinity DataKi:  3.30E+3nM ΔG°:  -31.3kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116204(US8637502, 16)
Affinity DataKi:  3.80E+3nM ΔG°:  -30.9kJ/molepH: 7.4 T: 2°CAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.2 nM[3H]-diprenorphi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDelta-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116200(US8637502, 12)
Affinity DataKi:  4.05E+3nM ΔG°:  -30.8kJ/molepH: 7.4 T: 2°CAssay Description:δ-Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 μg m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purde Pharma

US Patent
LigandPNGBDBM116210(US8637502, 44)
Affinity DataKi:  4.23E+3nM ΔG°:  -28.5kJ/molepH: 7.4 T: 2°CAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: